lovastatin has been researched along with Graft vs Host Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bassett, R; Champlin, RE; Couriel, DR; Jones, D; Khalili, J; Komanduri, KV; Li, D; Ma, Q; Molldrem, JJ; Sale, GE; Wang, Y | 1 |
Brandl, U; Detter, C; Kreuzer, E; Kur, F; Mair, H; Meiser, BM; Seidel, D; Thiery, J; Uberfuhr, P; Wenke, K | 1 |
1 trial(s) available for lovastatin and Graft vs Host Disease
Article | Year |
---|---|
Prevention and treatment of graft vessel disease after heart transplantation.
Topics: Adult; Arteriosclerosis; Blood Component Removal; Cholesterol; Double-Blind Method; Female; Graft Occlusion, Vascular; Graft vs Host Disease; Heart Transplantation; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Oligopeptides; Peptides, Cyclic; Prospective Studies; Risk Factors; Simvastatin; Somatostatin; Tissue Donors | 1995 |
1 other study(ies) available for lovastatin and Graft vs Host Disease
Article | Year |
---|---|
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Cell Adhesion; Cell Growth Processes; Cytokines; Graft vs Host Disease; Kaplan-Meier Estimate; Lovastatin; Lymph Nodes; Lymphocyte Activation; Lymphocyte Function-Associated Antigen-1; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Peyer's Patches; T-Lymphocytes | 2009 |